Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study
Condition: Ovarian Cancer Intervention: Drug: Enzalutamide 40 MG Sponsor: Grupo Español de Tumores Huérfanos e Infrecuentes Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials